首页> 外文期刊>Journal of Drug Delivery and Therapeutics >CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT
【24h】

CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT

机译:抗溶性增强剂的结晶工程

获取原文
           

摘要

In the current study, we attempted to improve the physicochemical properties of antiviral drug efavirenz through the cocrystal synthesis. The neat grinding performed to study the effect of coformer-fumaric acid (FA) on solubility and dissolution of efavirenz, which can serve as the green cocrystal synthesis approach. The prepared cocrystals were characterized for characteristics like powder flow properties, aqueous saturation solubility, in vitro powder dissolution study. The synthesized cocrystals were characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffraction. The formation of a cocrystal of efavirenz and caffeine was confirmed by the characterization techniques which suggests the interactions between efavirenz and coformer-fumaric acid leads to cocrystal formation. The powder flow properties, solubility, and dissolution profile of efavirenz are significantly improved by its cocrystallization.
机译:在当前的研究中,我们试图通过共晶合成来改善抗病毒药物依非韦伦的理化性质。进行了纯净研磨,研究了共富马酸(FA)对依非韦伦的溶解度和溶解度的影响,可作为绿色共晶合成方法。所制备的共结晶的特征在​​于粉末流动性,水饱和溶解度,体外粉末溶解研究等特性。通过傅立叶变换红外光谱,差示扫描量热法,粉末X射线衍射对合成的共晶体进行表征。依法韦仑和咖啡因的共结晶的形成已通过表征技术得到证实,这表明依法韦仑和共形成剂-富马酸之间的相互作用导致了共结晶的形成。依非韦伦的共结晶可显着改善其粉末流动性,溶解度和溶出度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号